Persistent hyperglycemia generating reactive oxygen species in renal cells, a probable cause of inflammation in type2 diabetic nephropathy subjects

Biomedical Research (India)

Volumn 23, Issue 4, 2012, Pages 501-504

  Kafle, Deepak ^a   Singh, Neelima ^a   Singh, S K ^a   Singh, Nivedita ^a   Bhargav, Vishal ^a   Singh, A K ^a  

^a G R MEDICAL COLLEGE   (India)

Author keywords

Diabetic nephropathy; Inflammation; Oxidative stress

Indexed keywords

CREATININE; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INTERLEUKIN 6; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UREA;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; KIDNEY CELL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; UREA BLOOD LEVEL;

EID: 84867253649     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Raine AEG. Epidemiology, development and treament of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. Diabetologia 1993; 36: 1099-1104.
2. Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol 2007; 106: 26-31.
3. Balakumar P, Chakkarwar VA, Kishan P. Vascular endothelial dysfunction: a tug of war in diabetic nephropathy? Biomed Pharmacother 2009; 63: 171-179.
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
5. Dursun E, Ozben T, Suleymanlar G, Dursun B, Yakupoglu G. Effect of hemodialysis on the oxidative stress and antioxidants. Clinical Chemistry of Laboratory Medicine 2002; 40: 1009-1013.
6. He Z, Rask-Madesen C, King GL. Pathogenesis of diabetic microvascular complications. In International Textbook of Diabetes Mellitus, Edition 3, Vol 2. Edited by De Fronzo R, et al. John Wiley & Sons 2004; 1135-1159.
7. He Z, King GL. Microvascular complications of diabetes. Endocrinol Metab Clin North Am 2004; 33: 215-xii.
8. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes, Endocr Rev 2002; 23: 599-622.
9. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes (1991); 40: 405-412.
10. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27: 813-823.
11. Kislinger T, Fu C, Huber BN (epsilon)-(carboxymeth-yl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 1999; 274: 31740-31749.
12. Trinder P. Ann Clin Biochem 1969; 6: 24.
13. Bermeyer HU and Gutmann I. Methods of enzymatic Analysis, ed Bermeyer HU, Academic Press, NY 1974; 4: 1794-1798.
14. Fabinyl DL, Ertingshausen G. Automated reaction rate method for determination of serum creatinine with Centrifi Chem Clin Chem 1971; 17: 696-700.
15. Bergmeyer HV. Method in Enzymatic Analysis, New York Academic Press 1963; pp 875-879.
16. Goldberg DM, Spooner RJ. Methods of Enzymatic Analysis (Bergmeyen HV Ed.) 1983; 3: (3) pp258-265, Verlog Chemie, Deerfield Beach, Fl.
17. Jean CD, Maryse T, Marie JF. Plasma Malondialdeh-yde levels during Myocardial infarction. Clinica Chimica Acta 1983; 129: 319-322.
18. Enzyme immunoassay for the in vitro determination of Tnf-α in serum. Kit for determination of Tnf-α, 96 wells (cat. # im1121)
19. Enzyme immunoassay for the in vitro determination of IL-6 in serum. Kit for determination of IL-6, 96 wells (cat. # im1120)
20. Vaishali S. Correlation of trace elements with status of antioxidant enzymes in normal pregnancy, pregnancy induced hypertension and menopausal state of women. Ph.D. thesis 2004.
21. Cvetkoviae T, Mitiae B, Lazareviae G, Vlahoviae P, Antiae S, Stefanoviae V. Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy. J Diab and Its Complications 2009; 23: 337-342.
22. Alexandraki K. Inflammatory process in type 2 diabetes. The role of cytokines. Ann NY Acad Sci 2006; 1084: 89-117.
23. Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008;19: 433-442.